These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8649047)

  • 1. High mortality after abdominal operation in patients with large-volume malignant ascites.
    Yazdi GP; Miedema BW; Humphrey LJ
    J Surg Oncol; 1996 Jun; 62(2):93-6. PubMed ID: 8649047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of malignant ascites in patients with advanced cancer: peritoneovenous shunt versus paracentesis.
    Seike M; Maetani I; Sakai Y
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2161-6. PubMed ID: 18031375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneovenous shunting for malignant ascites.
    Wickremesekera SK; Stubbs RS
    N Z Med J; 1997 Feb; 110(1037):33-5. PubMed ID: 9066565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and prevention of malignant ascites associated with disseminated intraperitoneal malignancies by aggressive combined-modality therapy.
    Loggie BW; Perini M; Fleming RA; Russell GB; Geisinger K
    Am Surg; 1997 Feb; 63(2):137-43. PubMed ID: 9012427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved quality of life for malignant ascites patients by Denver peritoneovenous shunts.
    Tomiyama K; Takahashi M; Fujii T; Kunisue H; Kanaya Y; Maruyama S; Yokoyama N; Nakao A; Soda M; Shimizu N
    Anticancer Res; 2006; 26(3B):2393-5. PubMed ID: 16821622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: an updated series.
    Caceres A; Zhou Q; Iasonos A; Gerdes H; Chi DS; Barakat RR
    Gynecol Oncol; 2008 Mar; 108(3):482-5. PubMed ID: 18190953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneovenous shunt in malignant ascites. The Bordet Institute experience from 1975-1998.
    Tueche SG; Pector JC
    Hepatogastroenterology; 2000; 47(35):1322-4. PubMed ID: 11100342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.
    Vergote I; De Wever I; Tjalma W; Van Gramberen M; Decloedt J; van Dam P
    Gynecol Oncol; 1998 Dec; 71(3):431-6. PubMed ID: 9887245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal pressures and clinical parameters of total paracentesis for palliation of symptomatic ascites in ovarian cancer.
    Gotlieb WH; Feldman B; Feldman-Moran O; Zmira N; Kreizer D; Segal Y; Elran E; Ben-Baruch G
    Gynecol Oncol; 1998 Dec; 71(3):381-5. PubMed ID: 9887235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneovenous shunt for palliation of gynecologic malignant ascites.
    Faught W; Kirkpatrick JR; Krepart GV; Heywood MS; Lotocki RJ
    J Am Coll Surg; 1995 Apr; 180(4):472-4. PubMed ID: 7536598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions.
    Chi DS; Abu-Rustum NR; Sonoda Y; Chen SW; Flores RM; Downey R; Aghajanian C; Barakat RR
    Gynecol Oncol; 2004 Aug; 94(2):307-11. PubMed ID: 15297166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneovenous shunting in the management of malignant ascites.
    Straus AK; Roseman DL; Shapiro TM
    Arch Surg; 1979 Apr; 114(4):489-91. PubMed ID: 86345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneovenous shunts in patients with intractable ascites: palliation at what price?
    Zervos EE; McCormick J; Goode SE; Rosemurgy AS
    Am Surg; 1997 Feb; 63(2):157-62. PubMed ID: 9012430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality.
    Russo MW; Sood A; Jacobson IM; Brown RS
    Am J Gastroenterol; 2003 Nov; 98(11):2521-7. PubMed ID: 14638358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chylous ascites after oncological abdominal surgery: incidence and treatment.
    Kaas R; Rustman LD; Zoetmulder FA
    Eur J Surg Oncol; 2001 Mar; 27(2):187-9. PubMed ID: 11289756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer.
    Munkarah A; Levenback C; Wolf JK; Bodurka-Bevers D; Tortolero-Luna G; Morris RT; Gershenson DM
    Gynecol Oncol; 2001 May; 81(2):237-41. PubMed ID: 11330956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of adverse surgical outcome in the management of malignant bowel obstruction.
    Medina-Franco H; García-Alvarez MN; Ortiz-López LJ; Cuairán JZ
    Rev Invest Clin; 2008; 60(3):212-6. PubMed ID: 18807733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma.
    Pothuri B; Meyer L; Gerardi M; Barakat RR; Chi DS
    Gynecol Oncol; 2004 Oct; 95(1):193-5. PubMed ID: 15385131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Laparoscopic intraperitoneal hyperthermic perfusion in palliation of malignant ascites. Case report].
    Graziosi L; Bugiantella W; Cavazzoni E; Donini A
    G Chir; 2009 May; 30(5):237-9. PubMed ID: 19505418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.